Literature DB >> 19545737

Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report.

B Fang1, Y P Song, N Li, J Li, Q Han, R C Zhao.   

Abstract

Herein we have reported the case of a man with chronic autoimmune thrombocytopenia (AITP) refractory to conventional therapy who underwent T-cell-depleted autologous peripheral blood stem cell (PBSC) transplantation. A complete, steroid-independent, platelet remission was obtained, but unfortunately he subsequently relapsed after 3 months. Finally, we administered human adipose tissue-derived mesenchymal stem cells (AMSC) with resolution to the AITP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545737     DOI: 10.1016/j.transproceed.2008.12.031

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Studies in adipose-derived stromal cells: migration and participation in repair of cranial injury after systemic injection.

Authors:  Benjamin Levi; Aaron W James; Emily R Nelson; Shijun Hu; Ning Sun; Michelle Peng; Joseph Wu; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2011-03       Impact factor: 4.730

Review 2.  Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.

Authors:  Ching-Shwun Lin; Guiting Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2012-07-03       Impact factor: 3.272

3.  Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells.

Authors:  Baijun Fang; Ling Mai; Ning Li; Yongping Song
Journal:  Stem Cells Dev       Date:  2011-08-12       Impact factor: 3.272

4.  Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy.

Authors:  Rachele Ciccocioppo; Maria L Russo; Maria E Bernardo; Federico Biagi; Laura Catenacci; Maria A Avanzini; Costanza Alvisi; Alessandro Vanoli; Rachele Manca; Ombretta Luinetti; Franco Locatelli; Gino R Corazza
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

Review 5.  Multipotent mesenchymal stromal cell therapy and risk of malignancies.

Authors:  Federica Casiraghi; Giuseppe Remuzzi; Mauro Abbate; Norberto Perico
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

Review 6.  Off-label use of adipose-derived stem cells.

Authors:  Francesco Simonacci; Nicolò Bertozzi; Edoardo Raposio
Journal:  Ann Med Surg (Lond)       Date:  2017-10-25

Review 7.  Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications.

Authors:  Mercedes Lopez-Santalla; Raquel Fernandez-Perez; Marina I Garin
Journal:  Cells       Date:  2020-08-07       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.